Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Dysfunctional Stromal Pathways Mark Early Changes within the Bone Marrow Microenvironment in JAK2 V617F-Driven Model of Myeloproliferative Neoplasm

Dennis M Bonal, Anna Dorota Chorzalska, Alissa Oakes, Makayla Pardo, Zoe Creane, Seo-Ho Lee, Omonike Oyelola, John L. Reagan, Adam Olszewski, Rabin Niroula, Stephen Donnelly, Joslyn Mills, Paul Bertone, Patrycja M Dubielecka

Blood (2023) 142 (Supplement 1): 3150.

https://doi.org/10.1182/blood-2023-189298

Published: 2023

Journal Articles

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Pamela Egan, Ari Pelcovits, Caitlyn Krar, Stephen Donnelly, Lila Rubin, Rabin Niroula, John L. Reagan, Dana Guyer, Adam J Olszewski, Thomas W LeBlanc

Blood (2023) 142 (Supplement 1): 259.

https://doi.org/10.1182/blood-2023-187645

Published: 2023

Journal Articles

Sry-Box Transcription Factor 9 (SOX9)-Driven Mesenchymal Stromal Cell Differentiation Signature As a Determinant of Induction Chemotherapy Responsiveness in Acute Myeloid Leukemia Core Bone Marrow Biopsies

Seo-Ho Lee, Dennis M Bonal, Diana Olguta Treaba, Anna Dorota Chorzalska, Makayla Pardo, John L. Reagan, Adam J Olszewski, Patrycja M. Dubielecka

Blood (2023) 142 (Supplement 1): 4299.

https://doi.org/10.1182/blood-2023-189679

Published: 2023

Journal Articles

Loss of Complement Factor I (Cfi) a Negative Regulator of Complement Cascade Activity Exacerbates JAK2V617F-Dependent Phenotype

Alissa Oakes, Dennis M Bonal, Zoe Creane, Hyunju Oh, Anna Dorota Chorzalska, Brooke Sadler, John L. Reagan, Rabin Niroula, Adam J Olszewski, Gabriel Haller, Stephen Donnelly, Patrycja M Dubielecka

Blood (2023) 142 (Supplement 1): 3149.

https://doi.org/10.1182/blood-2023-189483

Published: 2023

Journal Articles

Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

John L. Reagan, Rabin Niroula, Jessica McMahon, Pamela Egan, Inna Yakirevich, Mandy Pereira, Ari Pelcovits, Jeannine Margolis, Ashlee Sturtevant, Peter J. Quesenberry, Loren D. Fast

Blood (2023) 142 (Supplement 1): 6874.

https://doi.org/10.1182/blood-2023-177759

Published: 2023

Journal Articles

Alterations in Immune Cell Composition during First-Line Therapy with Mosunetuzumab for Follicular or Marginal Zone Lymphoma

Adam J Olszewski, Thomas Ollila, Ari Pelcovits, Anna Dorota Chorzalska, John Morgan, Jessica McMahon, Stephen Donnelly, Scott F. Huntington, Matthew Matasar, John L. Reagan, Charles Milrod, Patrycja M. Dubielecka

Blood (2023) 142 (Supplement 1): 1651.

https://doi.org/10.1182/blood-2023-181418

Published: 2023

Journal Articles

Inpatient Versus Outpatient Administration of Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia

Pranavi Sanka, Pamela Egan, Rabin Niroula, Inna Yakirevich, David Gardner, John L. Reagan

Blood (2023) 142 (Supplement 1): 4229.

https://doi.org/10.1182/blood-2023-184948

Published: 2023

Journal Articles

Assessment of Emergency Department Care for Patients with Acute Pain Crisis after the Formation of a Multidisciplinary Team

Taneisha Wilson, Katie Cherenzia, John L. Reagan, Dana L. Guyer, Catherine Trimbur, Jessica Nagy, Jon Meideros, Andrew Buksar, Priscilla Eskridge, David Gardner, Ilse Jenouri, Patrick T. McGann

Blood (2022) 140 (Supplement 1): 5013–5014.

https://doi.org/10.1182/blood-2022-170951

Published: 2022

Journal Articles

Complement Factor I (CFI) Deficiency Is Linked to Alterations in Humoral Immunity and Accelerated Development of JAK2V617F-Dependent Phenotype

Alissa Oakes, Anna D Chorzalska, Dennis M Bonal, John L Reagan, Patrycja M Dubielecka

Blood (2022) 140 (Supplement 1): 8721–8722.

https://doi.org/10.1182/blood-2022-170675

Published: 2022

Journal Articles

Successful Engraftment of Murine JAK2V617F MPN-like Disease into Unconditioned Mice

Dennis M Bonal, Anna D Chorzalska, Alissa Oakes, Valeria Brown, John L Reagan, Seo-Ho Lee, Patrycja M Dubielecka

Blood (2022) 140 (Supplement 1): 12158–12159.

https://doi.org/10.1182/blood-2022-170611

Published: 2022

Journal Articles

Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial

Blood (2022) 140 (Supplement 1): 2135–2136.

https://doi.org/10.1182/blood-2022-166996

Published: 2022

Journal Articles

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Pamela C Egan, Aryeh Pelcovits, Thomas W. Leblanc, Caitlyn Krar, Stephen Donnelly, Lila Rubin, Adam Olszewski, John L Reagan, Rabin Niroula

Blood (2022) 140 (Supplement 1): 7946–7947.

https://doi.org/10.1182/blood-2022-156951

Published: 2022

Journal Articles

Low Dose Irradiation Exhibits a Curative Potential in ABI1-Loss Driven Model of Myeloproliferative Neoplasm

Anna D Chorzalska, John Morgan, Diana O Treaba, Damali Simon-Ponte, Omonike Oyelola, John L Reagan, Patrycja M Dubielecka

Blood (2022) 140 (Supplement 1): 5880–5882.

https://doi.org/10.1182/blood-2022-170964

Published: 2022

Journal Articles

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

Peter Martin, Nancy L. Bartlett, Julio C. Chavez, John L. Reagan, Sonali M. Smith, Ann S. LaCasce, Jeffrey Jones, James Drew, Chengqing Wu, Erin Mulvey, Maria V. Revuelta, Leandro Cerchietti, John P. Leonard

Blood (2022) 139 (8): 1147–1159.

https://doi.org/10.1182/blood.2021011679

Published: 2022

Includes: Supplemental data

Journal Articles

Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies

Thomas A. Ollila, Rebecca Masel, John L Reagan, Kimberly Paiva, Shaolei Lu, Ralph Rogers, Adam Zayac, Rashida Taher, Inna Yakirevich, Rabin Niroula, Peter Barth, Adam J. Olszewski

Blood (2021) 138 (Supplement 1): 3511.

https://doi.org/10.1182/blood-2021-144304

Published: 2021

Journal Articles

Whole Genome Sequencing Identifies a Recurrent Mutation in Complement Factor I ( CFI ) in Primary Myelofibrosis (PMF)

Brooke Sadler, Anna D Chorzalska, Dennis M Bonal, Gabe Haller, Alissa Oakes, Max Petersen, Yuchen Liu, Adam Olszewski, John L Reagan, Pamela C Egan, Rabin Niroula, Diana O Treaba, Gabriela Hobbs, Stephen T. Oh, Jorge Di Paola, Joanna E Baxter, Patrycja M Dubielecka

Blood (2021) 138 (Supplement 1): 1472.

https://doi.org/10.1182/blood-2021-154281

Published: 2021

Journal Articles

Longitudinal Analysis of Hydroxyurea and Fetal Hemoglobin in Adult Patients with Sickle Cell Anemia

Aryeh Pelcovits, Giancarlo Riotto, Katie Cherenzia, Patrick T. McGann, John L Reagan

Blood (2021) 138 (Supplement 1): 2054.

https://doi.org/10.1182/blood-2021-153890

Published: 2021

Journal Articles

Levels of Osteopontin ( SPP1 ), Osteonectin ( SPARC ) and Biglycan ( BGN ) in Acute Myeloid Leukemia Bone Marrow Biopsies Post-Induction Therapy Define the Status of Osteogenic Niche and Show Inverse Correlation with Therapeutic Response

Diana O Treaba, MD, Dennis M Bonal, Anna D Chorzalska, PhD, Christoph Schorl, PhD, Kelsey Hopkins, John L Reagan, MD, Peter Rintels, MD, Peter J Quesenberry, MD, Patrycja M Dubielecka, PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142604

Published: 2020

Journal Articles

Tumor Lysis Syndrome Risk in Outpatient Versus Inpatient Administration of Venetoclax and Hypomethlators for Acute Myeloid Leukemia

Aryeh Pelcovits, MD, Brianna Bakow, MD, Jozal Waroich, Pamela C Egan, MD, Rabin Niroula, MBBS, Adam J Olszewski, MD, John L Reagan, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-133880

Published: 2020

Journal Articles

Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study

Thomas A Ollila, MD, James Butera, MD, Pamela C Egan, MD, John L Reagan, MD, Anthony G Thomas, DO, Inna Yakirevich, NP, Kelsey MacKinnon, Jeannine Margolis, Valerie Rosati, Jessica McMahon, RN, Jordan Robison, CRA, Adam J Olszewski, MD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-134054

Published: 2020

NARROW

Dysfunctional Stromal Pathways Mark Early Changes within the Bone Marrow Microenvironment in JAK2 V617F-Driven Model of Myeloproliferative Neoplasm

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Sry-Box Transcription Factor 9 (SOX9)-Driven Mesenchymal Stromal Cell Differentiation Signature As a Determinant of Induction Chemotherapy Responsiveness in Acute Myeloid Leukemia Core Bone Marrow Biopsies

Loss of Complement Factor I (Cfi) a Negative Regulator of Complement Cascade Activity Exacerbates JAK2V617F-Dependent Phenotype

Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Alterations in Immune Cell Composition during First-Line Therapy with Mosunetuzumab for Follicular or Marginal Zone Lymphoma

Inpatient Versus Outpatient Administration of Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia

Assessment of Emergency Department Care for Patients with Acute Pain Crisis after the Formation of a Multidisciplinary Team

Complement Factor I (CFI) Deficiency Is Linked to Alterations in Humoral Immunity and Accelerated Development of JAK2V617F-Dependent Phenotype

Successful Engraftment of Murine JAK2V617F MPN-like Disease into Unconditioned Mice

Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Low Dose Irradiation Exhibits a Curative Potential in ABI1-Loss Driven Model of Myeloproliferative Neoplasm

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies

Whole Genome Sequencing Identifies a Recurrent Mutation in Complement Factor I ( CFI ) in Primary Myelofibrosis (PMF)

Longitudinal Analysis of Hydroxyurea and Fetal Hemoglobin in Adult Patients with Sickle Cell Anemia

Levels of Osteopontin ( SPP1 ), Osteonectin ( SPARC ) and Biglycan ( BGN ) in Acute Myeloid Leukemia Bone Marrow Biopsies Post-Induction Therapy Define the Status of Osteogenic Niche and Show Inverse Correlation with Therapeutic Response

Tumor Lysis Syndrome Risk in Outpatient Versus Inpatient Administration of Venetoclax and Hypomethlators for Acute Myeloid Leukemia

Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only